NYXH Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance
Revenue, net income, margins and EPS trends
06
EPS$-2.362020-12-31 → 2025-12-31
Free Cash Flow$-70M2022-12-31 → 2025-12-31
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NYXH
5Y avg
Peer Median
Verdict
P/E
-1.95Y avg ≈-3.4
≈-3.4
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NYXH
5Y avg
Peer Median
Verdict
ROA
-65.1%5Y avg ≈-39.7%
≈-39.7%
·
·
ROE
-110.9%5Y avg ≈-57.5%
≈-57.5%
·
·
ROIC
-171.9%5Y avg ≈-74.7%
≈-74.7%
·
·
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NYXH
5Y avg
Peer Median
Verdict
Current Ratio
1.35Y avg ≈4.3
≈4.3
·
·
Quick Ratio
0.25Y avg ≈0.6
≈0.6
·
·
Interest Coverage
-7.25Y avg ≈-9.6
≈-9.6
·
·
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
NYXH
5Y avg
Peer Median
Verdict
EPS (Diluted)
$-2.365Y avg ≈$-1.62
≈$-1.62
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NYXH
5Y avg
Peer Median
Verdict
Inventory Turnover
0.85Y avg ≈1.0
≈1.0
·
·
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
14
Avg Surprise-4.0%
Period
Report
EPS Actual
EPS Est
Surprise
June 30, 2026
$-0.58
$-0.39
-46.5%
March 31, 2026
$-0.37
$-0.51
27.0%
Dec. 31, 2025
$-0.59
$-0.56
-5.5%
Sept. 30, 2025
$-0.63
$-0.60
-5.0%
June 30, 2025
$-0.55
$-0.58
5.2%
March 31, 2025
$-0.59
$-0.56
-5.5%
Dec. 31, 2024
$-0.46
$-0.47
2.1%
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement14
Metric
Trend
2025
2024
2023
2022
2021
Cost of Revenue
$4M
$2M
$2M
$1M
$303.0K
Gross Profit
$6M
$3M
$3M
$2M
$549.0K
R&D Expense
$43M
$34M
$27M
$16M
$12M
SG&A Expense
$48M
$28M
$22M
$19M
$15M
Operating Income
$-83M
$-59M
$-45M
$-32M
$-26M
Interest Expense
$12M
$5M
$4M
$4M
$2M
Interest Income
$6M
$7M
$4M
$7M
$4M
Pretax Income
$-89M
$-56M
$-45M
$-30M
$-25M
Income Tax
$1M
$3M
$-1M
$1M
$3M
Net Income
$-90M
$-59M
$-43M
$-31M
$-28M
EPS (Basic)
$-2.36
$-1.81
$-1.54
$-1.21
$-1.16
EPS (Diluted)
$-2.36
$-1.81
$-1.54
$-1.21
$-1.16
Shares (Basic)
38,108,434
32,743,605
27,968,142
25,819,165
23,792,693
EBITDA
$-83M
$-59M
$-45M
$-32M
·
Balance Sheet10
Metric
Trend
2025
2024
2023
2022
2021
Cash & Equivalents
$8M
$6M
$12M
$18M
$135M
Inventory
$5M
$5M
$3M
$882.0K
$346.0K
Current Assets
$61M
$98M
$68M
$100M
$140M
PP&E (Net)
$4M
$5M
$4M
$2M
$2M
Intangibles
$50M
$50M
$47M
$40M
$25M
Total Assets
$118M
$158M
$124M
$146M
$171M
Current Liabilities
$49M
$22M
$14M
$15M
$12M
Total Liabilities
$69M
$45M
$26M
$26M
$22M
Retained Earnings
$-306M
$-218M
$-161M
$-118M
$-87M
Stockholders' Equity
$49M
$113M
$98M
$120M
$149M
Cash Flow6
Metric
Trend
2025
2024
2023
2022
2021
Operating Cash Flow
$-69M
$-49M
$-45M
$-29M
$-25M
CapEx
$805.0K
$1M
$2M
$886.0K
$1M
Investing Cash Flow
$28M
$-16M
$32M
$-90M
$-12M
Financing Cash Flow
$38M
$77M
$17M
$-983.0K
$76M
Free Cash Flow
$-70M
$-50M
$-47M
$-30M
·
Levered FCF
$-81M
$-56M
$-51M
$-34M
·
Profitability3
Metric
Trend
2025
2024
2023
2022
2021
ROA
-65.1%
-41.9%
-32.0%
-19.7%
·
ROE
-110.9%
-56.1%
-39.6%
-23.2%
·
ROIC
-171.9%
-54.5%
-44.5%
-28.1%
·
Liquidity & Solvency3
Metric
Trend
2025
2024
2023
2022
2021
Current Ratio
1.3
4.6
4.7
6.7
·
Quick Ratio
0.2
0.3
0.9
1.2
·
Interest Coverage
-7.2
-11.6
-12.1
-7.5
·
Efficiency1
Metric
Trend
2025
2024
2023
2022
2021
Inventory Turnover
0.8
0.4
0.8
1.9
·
Per Share1
Metric
Trend
2025
2024
2023
2022
2021
EPS (TTM)
$-2.36
$-1.81
$-1.54
$-1.21
·
Valuation (TTM)3
Metric
Trend
2025
2024
2023
2022
2021
Net Income TTM
$-90M
$-59M
$-43M
$-31M
·
P/E
-1.9
-4.4
-3.0
-4.1
·
Earnings Yield
-51.4%
-22.6%
-33.3%
-24.2%
·
Per Share1
Metric
Trend
Q4 2021
EPS (TTM)
$-1.16
Valuation (TTM)3
Metric
Trend
Q4 2021
Net Income TTM
$-28M
P/E
-19.8
Earnings Yield
-5.1%
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Net Income
$-90M
$-59M
$-43M
$-31M
$-28M
Diluted EPS
$-2.36
$-1.81
$-1.54
$-1.21
$-1.16
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Current Ratio
1.3
4.6
4.7
6.7
·
Quick Ratio
0.2
0.3
0.9
1.2
·
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Free Cash Flow
$-70M
$-50M
$-47M
$-30M
·
Institutional owners (13F)
46 filers
· $36.2M total
· As of Sept. 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders46
Value held$36.2M
New positions19
Exited positions8
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
19 (+10 vs prior Q)
8 (+2 vs prior Q)
6 (+2 vs prior Q)
3 (-3 vs prior Q)
+17.6M
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.